• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Zolpidem IC50

The interaction of thrombopoietin (TPO) using its receptor c-Mpl initiates intracellular

August 27, 2018 by Katherine Lewis Leave a Comment

The interaction of thrombopoietin (TPO) using its receptor c-Mpl initiates intracellular signals that are crucial for megakaryopoiesis. Likewise, expression of the constitutively active edition of -catenin didn’t increase cell development either in the lack or existence of TPO, recommending that the consequences of GSK-3 inhibition downstream of TPO signaling are distinctive from those induced by … [Read more…]

Posted in: Blogging Tagged: Agt, Zolpidem IC50

Actin comes with an sick\defined function in the trafficking of GLUT4

September 7, 2017 by Katherine Lewis Leave a Comment

Actin comes with an sick\defined function in the trafficking of GLUT4 blood sugar transporter vesicles towards the plasma membrane (PM). been implicated in GLUT4 exocytosis 42. Traditional western blotting showed the fact that protein degrees of two of the elements, Sec8 and Myo1c, had been significantly raised in the WAT from the Tg mice (Body … [Read more…]

Posted in: Blogging Tagged: SMAD9, Zolpidem IC50

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by